106 related articles for article (PubMed ID: 97601)
1. [Treatment of peripheral vascular diseases with dihydroergocristine].
Moracchini PV; Alfano G; Melandri F
Minerva Cardioangiol; 1978 Apr; 26(4):277-90. PubMed ID: 97601
[No Abstract] [Full Text] [Related]
2. [Clinical treatment of peripheral arterial occlusive diseases].
Schulte B
Fortschr Med; 1976 Sep; 94(27):1500-4. PubMed ID: 823087
[TBL] [Abstract][Full Text] [Related]
3. [Controlled clinical study of use of dihydroergocristine in cerebral and periferal vascular disorders].
Calisti G; Biscarini L; Miseo A
Clin Ter; 1977 Nov; 83(4):371-86. PubMed ID: 414875
[No Abstract] [Full Text] [Related]
4. [Evaluation of the therapeutic effectiveness of a piracetam plus dihydroergocristine combination in the treatment of vertigo].
López Martínez R
Acta Otorrinolaringol Esp; 1988; 39(4):287-8. PubMed ID: 3152560
[No Abstract] [Full Text] [Related]
5. [Conservative treatment of peripheral arterial occlusive diseases].
Hoffmann J
Fortschr Med; 1978 Sep; 96(34):1735-8. PubMed ID: 101431
[TBL] [Abstract][Full Text] [Related]
6. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
Offerhaus L
Ned Tijdschr Geneeskd; 1981 Feb; 125(6):228-34. PubMed ID: 7207673
[No Abstract] [Full Text] [Related]
7. [Therapy of chronic arterial occlusive disease. Studies with an orally administered drug under ambulatory conditions].
Wampola H
Fortschr Med; 1977 May; 95(18):1240,1242-5. PubMed ID: 405291
[TBL] [Abstract][Full Text] [Related]
8. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
9. [Dihydroergocristine in the treatment of organic brain psychosyndrome. Dose-finding study against placebo].
Milvio C
Arzneimittelforschung; 1992 Nov; 42(11A):1399-402. PubMed ID: 1492861
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experiences with the vascular action of dihydroergocristine].
Tomasi AM; Baggioni GF; Pozzar C
Minerva Cardioangiol; 1975 Jan; 23(1):7-19. PubMed ID: 806854
[No Abstract] [Full Text] [Related]
11. [Reaction of the conjunctival and retinal vessels to the administration of vasodilators to patients with vascular disorders of the fundus oculi].
Davydova NG; Bunin AIa; Nikol'skaia VV; Lysenko VS; Iakovleva AA
Vestn Oftalmol; 1985; 101(3):38-40. PubMed ID: 4035869
[No Abstract] [Full Text] [Related]
12. [Dihydroergocristine in the treatment of Raynaud's disease].
Castelli PM; Sironi G
Minerva Cardioangiol; 1977 Sep; 25(9):757-63. PubMed ID: 413069
[No Abstract] [Full Text] [Related]
13. [Observations during ambulatory therapy of functional and organic circulatory disorders with Defluina].
Brüning G
Med Welt; 1975 Sep; 26(38):1737-41. PubMed ID: 810634
[No Abstract] [Full Text] [Related]
14. [Clinical trials with dihydroergocristine in patients with vascular and cerebral insufficiency].
Ingelmo M; Vivancos J; Peri J; Balcells Gorina A
Rev Clin Esp; 1980 Dec; 159(6):399-402. PubMed ID: 6784197
[No Abstract] [Full Text] [Related]
15. [Clinical and therapeutic experience in 151 consecutive protocolized cases with vertigo syndrome of cervical origin. Comparative study of a cinnarizine and dihydroergocristine combination with a cinnarizine and dihydroergocristine plus anti-inflammatory agents combination].
Bartual J; Vidal J; Magro E; Roquette J
Acta Otorrinolaringol Esp; 1988; 39(5):331-8. PubMed ID: 3152492
[No Abstract] [Full Text] [Related]
16. [Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes].
Ordosgoitia H; Castro C; Carbayeda M; Labella T
An Otorrinolaringol Ibero Am; 1989; 16(3):271-9. PubMed ID: 2502041
[TBL] [Abstract][Full Text] [Related]
17. [Parameters for the measurement of long-term effects of an orally administered drug in organic and functional circulatory disorders. Preliminary communication].
Schuster CJ; von Ungern-Sternberg AF
ZFA (Stuttgart); 1976 Jan; 52(2):105-10. PubMed ID: 817527
[No Abstract] [Full Text] [Related]
18. [Effects of short-term and long-term (5 years) administration of a new preparation for the treatment of arterial hypertension].
Bonomini V; Vangelista A; Fatone F
G Clin Med; 1976; 57(1-2):46-65. PubMed ID: 828115
[No Abstract] [Full Text] [Related]
19. [Epidemiologic study on the effectiveness and safety of dihydroergocristine in impaired memory and behavioral functions in aged humans].
Abate G; Angeleri F; Bartorelli L; Battistin L; Bergamasco B; Bertolini S; Bulfoni A; Capurso A; Cazzato G; Coccagna G
Arzneimittelforschung; 1992 Nov; 42(11A):1417-21. PubMed ID: 1492866
[TBL] [Abstract][Full Text] [Related]
20. Use of Redergam (Latergal) in vascular diseases.
Kovács E
Ther Hung; 1986; 34(4):238-42. PubMed ID: 3449979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
